| scholarly article | Q13442814 |
| P50 | author | Lothar Elling | Q41704361 |
| P2093 | author name string | Dominic Laaf | |
| Sophia Böcker | |||
| P2860 | cites work | Serum level of galectin-3 in human bladder cancer | Q80818989 |
| Synthesis of a pentasaccharide and neoglycoconjugates related to fungal α-(1→3)-glucan and their use in the generation of antibodies to trace Aspergillus fumigatus cell wall | Q85922405 | ||
| Galectin-3 in angiogenesis and metastasis. | Q27687444 | ||
| Galectins. Structure and function of a large family of animal lectins | Q28246794 | ||
| What is Cooperativity? | Q29302467 | ||
| Biological roles of oligosaccharides: all of the theories are correct | Q29616459 | ||
| The Quantification of Protein Amino Groups by the Trinitrobenzenesulfonic Acid Method: A Reexamination | Q30427705 | ||
| Enzymatic synthesis of natural and 13C enriched linear poly-N-acetyllactosamines as ligands for galectin-1. | Q30656651 | ||
| Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori | Q31158199 | ||
| Galectins and gliomas | Q33588438 | ||
| The cluster glycoside effect | Q34113785 | ||
| Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry | Q34172998 | ||
| Presence of terminal N-acetylgalactosamineβ1-4N-acetylglucosamine residues on O-linked oligosaccharides from gastric MUC5AC: involvement in Helicobacter pylori colonization? | Q34250321 | ||
| Affinity enhancement by multivalent lectin-carbohydrate interaction | Q34290899 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Platelets and galectins | Q34385152 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Neoglycoproteins as carbohydrate antigens: synthesis, analysis, and polyclonal antibody response | Q34772502 | ||
| Binding and cross-linking properties of galectins | Q34837917 | ||
| Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier | Q35017926 | ||
| Multivalent glycoconjugates as anti-pathogenic agents | Q35444698 | ||
| Introduction to galectins | Q35646606 | ||
| Intact reducing glycan promotes the specific immune response to lacto-N-neotetraose-BSA neoglycoconjugates | Q35897201 | ||
| Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. | Q35945071 | ||
| Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment | Q36073585 | ||
| On the role of galectin-3 in cancer apoptosis | Q36103556 | ||
| Preparation of glycoconjugates by dialkyl squarate chemistry revisited | Q36492952 | ||
| Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens | Q36741513 | ||
| Use of diethyl squarate for the coupling of oligosaccharide amines to carrier proteins and characterization of the resulting neoglycoproteins by MALDI-TOF mass spectrometry | Q36810831 | ||
| Clustered carbohydrates in synthetic vaccines | Q36844110 | ||
| Design and synthesis of glycoprotein-based multivalent glyco-ligands for influenza hemagglutinin and human galectin-3. | Q37080060 | ||
| Functional roles of N-glycans in cell signaling and cell adhesion in cancer | Q37168602 | ||
| N-Glycans in cancer progression | Q37243167 | ||
| Glycobiology of immune responses | Q37448685 | ||
| Membrane permeabilization by multivalent anti-microbial peptides | Q37551058 | ||
| Neoglycoproteins as tools in glycohistochemistry. | Q37754252 | ||
| Glycosylation, galectins and cellular signaling | Q37880455 | ||
| Sweet carbon nanostructures: carbohydrate conjugates with carbon nanotubes and graphene and their applications. | Q38068070 | ||
| Carbosilane glycodendrimers. | Q38069059 | ||
| Bacterial toxin inhibitors based on multivalent scaffolds | Q38069445 | ||
| Glyconanoparticles as multifunctional and multimodal carbohydrate systems. | Q38071545 | ||
| Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions. | Q38076027 | ||
| Enzymatic glycosylation of multivalent scaffolds | Q38076635 | ||
| Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking. | Q38077702 | ||
| Multivalent glycoconjugate syntheses and applications using aromatic scaffolds | Q38080745 | ||
| Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives | Q38120012 | ||
| Be squared: expanding the horizon of squaric acid-mediated conjugations | Q38123105 | ||
| Galectin-3 in cancer. | Q38188296 | ||
| Galectins and neovascularization in central nervous system tumors | Q38214808 | ||
| Glycans and galectins in prostate cancer biology, angiogenesis and metastasis | Q38221080 | ||
| Expression of LacdiNAc groups on N-glycans among human tumors is complex | Q38227185 | ||
| Galectin-3: an emerging all-out player in metabolic disorders and their complications | Q38258947 | ||
| Fluorescent SNAP-tag galectin fusion proteins as novel tools in glycobiology. | Q50494734 | ||
| Allosteric, chelate, and interannular cooperativity: a mise au point. | Q51602276 | ||
| Combining carbohydrate substitutions at bioinspired positions with multivalent presentation towards optimising lectin inhibitors: case study with calixarenes. | Q51768317 | ||
| Identification and Quantification of Protein Glycosylation | Q58703048 | ||
| The LacdiNAc-Specific Adhesin LabA Mediates Adhesion of Helicobacter pylori to Human Gastric Mucosa | Q60403350 | ||
| Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin | Q61632645 | ||
| Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of neoglycoprotein in the histochemical detection of lectins | Q68030800 | ||
| Neoglycoproteins. Preparation and in vivo clearance of serum albumin derivatives containing ovalbumin oligosaccharides | Q70603254 | ||
| Removal of fatty acids from serum albumin by charcoal treatment | Q72200044 | ||
| A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin | Q74490796 | ||
| The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy | Q79916220 | ||
| Galectins in tumor angiogenesis | Q38269050 | ||
| Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands | Q38286204 | ||
| Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates | Q38290249 | ||
| Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regula | Q38290534 | ||
| Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional alpha 2,3/alpha 2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake | Q38293114 | ||
| Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting | Q38293785 | ||
| Lactose-functionalized dendrimers arbitrate the interaction of galectin-3/MUC1 mediated cancer cellular aggregation | Q38304880 | ||
| Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants | Q38321186 | ||
| L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion | Q38322976 | ||
| LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition | Q38338674 | ||
| Synthesis of a BSA-Le(x) glycoconjugate and recognition of Le(x) analogues by the anti-Le(x) monoclonal antibody SH1: the identification of a non-cross reactive analogue | Q38340863 | ||
| Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes | Q38346878 | ||
| Differential expression of LacdiNAc sequences (GalNAc beta 1-4GlcNAc-R) in glycoproteins synthesized by Chinese hamster ovary and human 293 cells | Q38347982 | ||
| Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors. | Q38351287 | ||
| Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. | Q38355470 | ||
| Glyco-DNA-gold nanoparticles: lectin-mediated assembly and dual-stimuli response. | Q39741194 | ||
| Neoglycoproteins: the preparation and application of synthetic glycoproteins. | Q40289145 | ||
| Concentrations of galectin-3 in the sera of normal controls and cancer patients | Q40884459 | ||
| Facile preparation of fluorescent neoglycoproteins using p-nitrophenyl anthranilate as a heterobifunctional linker | Q41791108 | ||
| Ligand induced galectin-3 protein self-association | Q41853356 | ||
| Multivalent scaffolds induce galectin-3 aggregation into nanoparticles | Q41890780 | ||
| Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3. | Q41951811 | ||
| Rapid screening of lectins for multivalency effects with a glycodendrimer microarray | Q42951736 | ||
| Bivalent inhibition of human beta-tryptase | Q43590396 | ||
| Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides | Q44630393 | ||
| The neoglycoprotein mannose-bovine serum albumin, but not progesterone, activates T-type calcium channels in human spermatozoa | Q44860950 | ||
| Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry | Q44994470 | ||
| Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. | Q45158458 | ||
| Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction | Q45257600 | ||
| Fucosyl neoglycoprotein binds to mouse epididymal spermatozoa and inhibits sperm binding to the egg zona pellucida | Q45270681 | ||
| Glycosylated nanoscale surfaces: preparation and applications in medicine and molecular biology | Q46298732 | ||
| Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces | Q46402283 | ||
| Probing multivalent carbohydrate-lectin interactions by an enzyme-linked lectin assay employing covalently immobilized carbohydrates | Q46983796 | ||
| Maximising multivalency effects in protein-carbohydrate interactions | Q47864899 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 1671-1696 | |
| P577 | publication date | 2015-07-24 | |
| P1433 | published in | Biomolecules | Q23929963 |
| P1476 | title | Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3 | |
| P478 | volume | 5 |
| Q91286868 | A human expression system based on HEK293 for the stable production of recombinant erythropoietin |
| Q58713956 | Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3 |
| Q41704323 | Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3. |
| Q47810391 | Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands. |
| Q51002174 | Exploring the Structural Space of the Galectin-1-Ligand Interaction. |
| Q92081930 | Functional Glyco-Nanogels for Multivalent Interaction with Lectins |
| Q47653100 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update |
| Q48159532 | Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling |
| Q38928047 | Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update |
| Q98771478 | Targeting Galectins With Glycomimetics |
| Q55379330 | Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors. |
| Q26744538 | Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer |
Search more.